Share Prices & Company Research

Market News

25 Jun 2019 | 13:22

Angle to raise £18m to invest in products, cut debt

Liquid biopsy company Angle launched a share issue to raise £18.0m to develop its products, establish a service laboratroy and strengthen its balance sheet.

News shares in the company were being offered at 61.5p each.

'We are grateful for the strong support of existing and new shareholders as we build our business to address the global liquid biopsy market,' chief executive Andrew Newland said.

'As well as strengthening the company's balance sheet in preparation for negotiating corporate partnerships, the proceeds from the placing will allow us to establish a clinically approved service laboratory to drive business from pharmaceutical drug trials and accelerate use of the Parsortix system for treating patients.'

At 1:22pm: (LON:AGL) Angle PLC share price was +4p at 65.5p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.